CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¿Àµµ¿¬
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : Ç÷¾×, Ç÷ÀüÁöÇ÷
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
186 ÇØ¿Ü Raskob GE, van Es N, Seger A, Angchaisuksiri P, Oh D, Boda Z, Lyons R,. Meijer K,. Gudz I, Weitz JI, Zhang G, Lanz H, Mercur MF, Büller HR. Edoxaban for venous thromboembolism in cancer patients: subgroup results from the Hokusai-VTE randomized trial. Lancet Haematol 2016 Aug;3(8):e379-87.  
185 ±¹³» Cho HJ, Chong SY, Kim JO, Huh JY, Kim NK, Park Y, Kim MG, Oh D. A case of atypical hemolytic uremic syndrome associated with c.1273C>T mutation in the complement C3 gene. Blood Res 2016 Sep;51(3):210-213  
184 ÇØ¿Ü Brekelmans MP, Bleker SM, Bauersachs R, Boda Z, Büller HR, Choi Y, Gallus A, Grosso MA, Middeldorp S, Oh D, Raskob G, Schwocho L, Cohen AT. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. 2016 Thromb Haemost Jul 4;116(1):155-61  
183 ÇØ¿Ü Nakamura M, Wang YQ, Wang C, Oh D, Yin WH, Kimura T, Miyazaki K, Abe K, Mercuri M, Lee LH, Segers A, Büller H. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost. 2015 Sep;13(9):1606-14.  
182 ÇØ¿Ü Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, Grandone E, Pasca S, Di Minno MN, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Oh D, D"Amico E, Becattini C, De Stefano V, Vidili G, Vaccarino A, Nardo B, Di Nisio M, Dentali F. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015 Sep 1;175(9):1474-80.  
181 ÇØ¿Ü Cho SH, Ko JJ, Kim JO, Jeon YJ, Yoo JK, Oh J, Oh D, Kim JW, Kim NK. Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population. PLoS One. 2015 Jul 6;10(7):e01311253"-UTR  
180 ÇØ¿Ü Kim JW, Jeon YJ, Jang MJ, Kim JO, Chong SY, Ko KH, Hwang SG, Oh D, Oh J, Kim NK. Association between folate metabolism-related polymorphisms and colorectal cancer risk. Mol Clin Oncol. 2015 May;3(3):639-648.  
179 ÇØ¿Ü Kim HY, Lee KO, Yoo KH, Kim SH, Oh D, Kim HJ. Congenital thombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) caused by novel ADAMTS13 mutations. Br J Haematol. 2015 Jun 18. doi: 10.1111/bjh.13564  
178 ÇØ¿Ü Joo Jeon Y, Woo Kim J, Mi Park H, Kim JO, Geun Jang H, Oh J, Gyu Hwang S, Won Kwon S, Oh D, Keun Kim N. Genetic variants in 3"-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans. Sci Rep. 2015 Jun 5;5:11006. doi: 10.1038/srep11006.  
177 ÇØ¿Ü Yhim HY, Jang MJ, Bang SM, Kim KH,  Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW, Oh D. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2014 Jul;12(7):1035-43.  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729